Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Milk-Based drink beat gatorade for Hot-Weather cycling?

NCT ID NCT07658820

Knowledge-focused Sponsor: Arizona State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a sports drink made from milk permeate (a byproduct of milk processing) helps cyclists perform better in the heat. Fourteen active cyclists will drink either water, a standard sports drink, or a milk-permeate drink during cycling sessions. Researchers measure how fast they complete a 5-kilometer time trial, their reaction time, and hydration levels. The goal is to see if the milk-permeate drink, which contains carbohydrates and electrolytes, improves physical and mental performance compared to other options.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
milk permeate-based sports drink
What this could lead to
If effective, this drink could offer a better way to stay hydrated and maintain performance during exercise in the heat.
What could go wrong
This is a small, early-stage study with only 14 participants, so results may not apply to everyone. The drink may not outperform standard sports drinks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 14 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy and injury free (muscle, skeletal) for greater than 2 months * Active cyclists who train at least 3 times per week * Body mass index (BMI) range of 18.5-30 kg/m2 * VO₂max ≥ 51 mL/kg/min for male participants * VO₂max ≥ 45 mL/kg/min for female participants Exclusion Criteria: * Taking medicine influences the cardiovascular system * non-steroidal anti-inflammatory drugs during the last week * Cancer Diagnosis during the last 5 years * Current Pregnancy * History of renal disease, hypertension, obstructive gastrointestinal tract disease, disorders or impairment of the gag reflex, previous gastrointestinal surgery * History of heat stroke * Use of testosterone therapy * Adults who are unable to consent (impaired decision-making capacity) * Adults having Felinization of the esophagus * Adults who will undergo Nuclear Magnetic Resonance (NMR) or MRI scanning within 3 days of swallowing a temperature sensitive pills

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dehydration (physiology) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Dehydration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dehydration (physiology) Hydration Performance

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 850 Phoenix Bioscience Core

    Phoenix, Arizona, 85004, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.